Home > Offer to Sell > Pharmaceuticals and Biochemicals > Auxiliaries and miscellaneous medicinal chemicals > 99% Progesterone Estrogen Steroids Altrenogest 850-52-2 for Female Body Care
99% Progesterone Estrogen Steroids Altrenogest 850-52-2 for Female Body Care
Inquiry
| Post Date: | Nov 14,2017 |
| Expiry Date: | Nov 14,2018 |
| Detailed Description: |
Cas No. :850-52-2
Quantity: 1000Kilograms Specs:10g foil bags Price:1 USD Kilograms Payment Method: Western union, money gram, t/t, btc 99% Progesterone Estrogen Steroids Altrenogest 850-52-2 for Female Body Care What is Altrenogest? Altrenogest is a synthetic trienic C21 steroidal progestomimetic, belonging to the 19-nor-testosterone series. It is an orally active (pro)gestagen. Like all steroids, altrenogest acts by its liposolubility by penetrating the target cells where it binds to specific receptors. In veterinary medicine, altrenogest is used in gilts and mares for zootechnical purposes (oestrus synchronization). Quick Details: Product Name: Altrenogest Synonyms: 17-allyltrenbolone;r2267;ru2267;ALLYLTRENBOLONE CAS: 850-52-2 MF: C21H26O2 MW: 310.43 EINECS: 212-703-1 Product Categories: Hormone;Intermediates & Fine Chemicals;Pharmaceuticals;Steroids;Steroid and Hormone;FLUDARA storage temp. 0-6ºC Chemical Properties Pale Yellow Solid Usage A synthetic progestational agent used in veterinary medicine for the control of estrus in mares. Description: Progestins are primarily produced endogenously by the corpus luteum. They transform proliferative endometrium to secretory endometrium, enhance myometrium hypertrophy and inhibit spontaneous uterine contraction. Progestins have a dose-dependent inhibitory effect on the secretion of pituitary gonadotropins and also have some degree of estrogenic, anabolic and androgenic activity. Altrenogest (or allyltrenbolone) is a synthetic trienic C21 steroidal progestomimetic, belonging to the 19-nor-testosterone series. It is an orally active (pro)gestagen. Like all steroids, altrenogest acts by its liposolubility by penetrating the target cells where it binds to specific receptors. Application: The pharmacodynamic activity of altrenogest has been demonstrated in a number of animal models. The most important effects are the progestomimetic and anti-gonadotrophic effects. Altrenogest also has weak oestrogenic, anabolic and androgenic effects, but has no corticoid or anti-inflammatory effects. Altrenogest is indicated (labeled) to suppress estrus in mares to allow a more predictable occurrence of estrus following withdrawal of the drug. It is used clinically to assist mares to establish normal cycles during the transitional period from anestrus to the normal breeding season often in conjunction with an artificial photoperiod. It is more effective in assisting in pregnancy attainment later in the transition period. One group of authors (Squires et al. 1983) suggest selecting mares with considerable follicular activity (mares with one or more follicles 20 mm or greater in size) for treatment during the transitional phase. Mares that have been in estrus for 10 days or more and have active ovaries are also considered to be excellent candidates for progestin treatment. Specifications: Test Items Specification Test Results Description White or almost white crystalline powder White crystalline powder Melting Point 191.0~193.0ºC 192ºC Loss of drying ≤1.0% 0.5% Heavy Metal ≤20ppm 15ppm TLC Only one spot Only one spot Assay ≥99.5% 99.91% Conclusion It complies with the USP 32. Dosage: In veterinary medicine, altrenogest is used in gilts and mares for zootechnical purposes (oestrus synchronization). The recommended dose for gilts is 20 mg/animal/day given orally for 18 consecutive days, and for mares is 0.044 mg/kg bw/day given orally for 10 to 15 days. Use: Altrenogest is indicated (labeled) to suppress estrus in mares to allow a more predictable occurrence of estrus following withdrawal of the drug. It is used clinically to assist mares to establish normal cycles during the transitional period from anestrus to the normal breeding season often in conjunction with an artificial photoperiod. It is more effective in assisting in pregnancy attainment later in the transition period. One group of authors (Squires et al. 1983) suggest selecting mares with considerable follicular activity (mares with one or more follicles 20 mm or greater in size) for treatment during the transitional phase. Mares that have been in estrus for 10 days or more and have active ovaries are also considered to be excellent candidates for progestin treatment. Altrenogest is effective in normally cycling mares for minimizing the necessity for estrus detection, for the synchronization of estrus and permitting scheduled breeding. Estrus will ensue 2-5 days after treatment is completed and most mares ovulate between 8-15 days after withdrawal. Altrenogest is also effective in suppressing estrus expression in show mares or mares to be raced. Although the drug is labeled as contraindicated during pregnancy, it has been demonstrated to maintain pregnancy in oophorectomized mares and may be of benefit in mares who abort due to sub-therapeutic progestin levels. More products: Testosterone Acetate CAS: 1045-69-8 Testosterone Cypionate CAS: 58-20-8 Testosterone Decanoate CAS: 5721-91-5 Testosterone Enanthate CAS: 315-37-7 Testosterone Isocaproate CAS: 15262-86-9 Testosterone Phenylpropionate CAS: 1255-49-8 Testosterone Propionate CAS: 57-85-2 Testosterone Undecanoate CAS: 5949-44-0 Testosterone Sustanon / Sustanon 250 CAS: Sustanon 250 Testo-ster-on-e CAS: 58-22-0 Trenbolone Acetate CAS: 10161-34-9 Trenbolone Enanthate CAS: 2322-77-2 Trenbolone Cyclohexylmethylcarbonate CAS: 23454-33-3 Tren-bol-on-e CAS: 10161-33-8 Turinabol CAS: 2446-23-3 Tetrabutylammonium Bromide CAS: 1643-19-2 Anavar / Oxan-dro-lon-e CAS: 53-39-4 Anadrol / Oxym-etho-lon-e CAS: 434-07-1 Angiotensin Acetate CAS: 58-49-1 Benzocaine CAS: 94-09-7 Boldenone Acetate CAS: 2363-59-9 Boldenone Cypionate CAS: 106505-90-2 Boldenone Undecylenate CAS: 13103-34-9 Boldneone CAS: 846-48-0 Carisoprodol CAS: 78-44-4 Drostanolone Enanthate CAS: 472-61-1 Drostanolone Propionate CAS: 521-12-0 Dehy-droi-soan-dros-ter-ones(D-H-E-A) CAS: 53-43-0 Methenolone Acetate CAS: 434-05-9 Methenolone Enanthate CAS: 303-42-4 Metandienone / Methandrostenolone / Dianabol CAS: 72-63-9 Melanotan II CAS: 121062-08-6 Nandrolone Decanoate / Deca Durabolin CAS: 360-70-3 Nandrolone Phenylpropionate CAS: 62-90-8 Liothyronine Sodium / T3 / cytomel CAS: 55-06-1 Stanolone CAS: 521-18-6 |
| CAS Registry Number: | 850-52-2 |
| Synonyms: | ;17-hydroxy-17-(prop-2-en-1-yl)estra-4,9,11-trien-3-one;(17beta)-17-hydroxy-17-(prop-2-en-1-yl)estra-4,9,11-trien-3-one;17a-allyl-trenbolone; |
| Molecular Formula: | C21H26O2 |
| Molecular Weight: | 310.4299 |
| Molecular Structure: | 
|
| Company: | Hengyang Desen Biotechnology Co., Ltd. [ China ] |
| Contact: | Koala |
| Tel: | +86-073-48164621 |
| Fax: | |
| Email: | koala@desen-nutrition.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
